These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20633303)

  • 21. The budget impact and cost-effectiveness of defibrotide for treatment of veno-occlusive disease with multi-organ dysfunction in patients post-hematopoietic stem cell transplant.
    Veenstra DL; Guzauskas GF; Villa KF; Boudreau DM
    J Med Econ; 2017 May; 20(5):453-463. PubMed ID: 28008770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-utility analysis of transcatheter aortic valve implantation versus surgery in severe aortic stenosis patients with intermediate surgical risk in Thailand.
    Permsuwan U; Yoodee V; Buddhari W; Wongpraparut N; Thonghong T; Cheewatanakornkul S; Meemook K; Sakiyalak P; Duangpakdee P; Yadee J
    J Geriatr Cardiol; 2022 Nov; 19(11):822-832. PubMed ID: 36561052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of pharmacist-participated warfarin therapy management in Thailand.
    Saokaew S; Permsuwan U; Chaiyakunapruk N; Nathisuwan S; Sukonthasarn A; Jeanpeerapong N
    Thromb Res; 2013 Oct; 132(4):437-43. PubMed ID: 24041634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of denosumab for high-risk postmenopausal women with osteoporosis in Thailand.
    Pongchaiyakul C; Nanagara R; Songpatanasilp T; Unnanuntana A
    J Med Econ; 2020 Jul; 23(7):776-785. PubMed ID: 32063082
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand.
    Krittayaphong R; Permsuwan U
    Am J Cardiovasc Drugs; 2018 Oct; 18(5):405-413. PubMed ID: 29926351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand.
    Permsuwan U; Chaiyakunapruk N; Dilokthornsakul P; Thavorn K; Saokaew S
    Appl Health Econ Health Policy; 2016 Jun; 14(3):281-92. PubMed ID: 26961276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure in Thailand.
    Permsuwan U; Phrommintikul A; Silavanich V
    Clinicoecon Outcomes Res; 2020; 12():579-588. PubMed ID: 33116697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic Evaluation of Human Rotavirus Vaccine in Thailand.
    Saokaew S; Prasitsuebsai W; Bibera GL; Kengkla K; Zhang XH; Oh KB; Lee C
    Infect Dis Ther; 2019 Sep; 8(3):397-415. PubMed ID: 31197662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand.
    Permsuwan U; Dilokthornsakul P; Thavorn K; Saokaew S; Chaiyakunapruk N
    J Med Econ; 2017 Feb; 20(2):171-181. PubMed ID: 27645706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
    Teerawattananon Y; Mugford M; Tangcharoensathien V
    Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation.
    Dilokthornsakul P; Nathisuwan S; Krittayaphong R; Chutinet A; Permsuwan U
    Heart Lung Circ; 2020 Mar; 29(3):390-400. PubMed ID: 31000364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-utility analysis of sutureless and rapid deployment versus conventional aortic valve replacement in patients with moderate to severe aortic stenosis in Thailand.
    Permsuwan U; Singhatanadgige S; Boonpipattanapong K; Slisatkorn W; Chartrungsan A; Nitayavardhana P; Luangthong N; Porapakkham P; Yadee J
    PLoS One; 2024; 19(1):e0296875. PubMed ID: 38241391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic Evaluation and Budget Impact Analysis of Vaccination against
    Kotirum S; Muangchana C; Techathawat S; Dilokthornsakul P; Wu DB; Chaiyakunapruk N
    Front Public Health; 2017; 5():289. PubMed ID: 29209602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Utility Analysis of Universal Maternal Pertussis Immunisation in Thailand: A Comparison of Two Model Structures.
    Botwright S; Win EM; Kapol N; Benjawan S; Teerawattananon Y
    Pharmacoeconomics; 2023 Jan; 41(1):77-91. PubMed ID: 36348154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis.
    Aungsumart S; Turongkaravee S; Youngkong S; Apiwattanakul M; Thakkinstian A; Chaikledkaew U
    BMC Health Serv Res; 2023 Oct; 23(1):1096. PubMed ID: 37833729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients.
    Foocharoen C; Kingkaew P; Teerawattananon Y; Mahakkanukrauh A; Suwannaroj S; Manasirisuk W; Chaiyarit J; Sangchan A
    Int J Rheum Dis; 2023 Oct; 26(10):2037-2046. PubMed ID: 37665078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(6):1-51. PubMed ID: 27110317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal Syndrome.
    Sangroongruangsri S; Kittrongsiri K; Charatcharoenwitthaya P; Sobhonslidsuk A; Chaikledkaew U
    Clinicoecon Outcomes Res; 2021; 13():703-715. PubMed ID: 34349534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan.
    Ho WL; Chung KP; Yang SS; Lu MY; Jou ST; Chang HH; Yang YL; Lin DT; Lin KH
    J Formos Med Assoc; 2013 Apr; 112(4):221-9. PubMed ID: 23537869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost-effectiveness analysis of laparoscopic hepatectomy compared with open liver resection in the early stage of hepatocellular carcinoma: a decision-analysis model in Thailand.
    Singhirunnusorn J; Niyomsri S; Dilokthornsakul P
    HPB (Oxford); 2022 Feb; 24(2):183-191. PubMed ID: 34238678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.